Find a Condition by Name
Health & Wellness Information
Find a Doctor by Name
Departments & Divisions
Locations & Maps
Forms & Medical Records
Travel & Lodging
Becoming a Patient
Patient Safety & Care
Health & Wellness Tips
Patient Education & Support
Professional Education - CME/CE
Adult Clinical Trials
Pediatric Clinical Trials
See All Trials
Core Labs & Diagnostics
Tucker Medical Library
Gifts of Assets
Our researchers are currently in need of adult and pediatric study participants to help us pursue better treatments and cures. Participants may receive medical evaluations and procedures, study medication, disease-related education and possible financial compensation for time, travel and participation.
National Jewish Health researchers are studying the antibody response to COVID-19 vaccines in people with chronic conditions.
Researchers want to understand how the body of a person with active lung cancer responds to
COVID-19, should they contract the virus.
U.S. military personnel and contractors who served in Iraq, Afghanistan and southwest Asia are contracting severe lung disease, and researchers want to know why.
Researchers are asking healthy adults, 25-35 years old, to join a five-year study exploring factors that may affect lung health with the goal of understanding lung disease.
The purpose of this study is to collect data on what drives asthma in the body and how it reacts depending on the environment and treatment.
Researchers are working to understand the different ways sarcoidosis, a disease that causes scarring in the lungs, develops.
Researchers are studying the differences in the skin and immune cells of people with food allergies and eczema, and those without.
National Jewish Health researchers are trying to determine why people with atopic dermatitis or eczema are more susceptible to bacterial infections. Learn how you can participate in our research study.
By participating in our study, you can help forward research on lung disease. Our researchers are hoping to learn more about the blood cells involved in the development of scarring lung diseases and create new treatment therapies.